Therapeutic CD154 antibody for lupus: promise for the future?
Publication
, Journal Article
Kelsoe, G
Published in: J Clin Invest
November 2003
Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease characterized by the production of pathogenic autoantibodies. A new study demonstrates that passive antibody specific for the TNF family member, CD154, ameliorates disease by reducing levels of self-reactive antibody in the serum. This study demonstrates a substantial potential for anti-CD154 antibody in the treatment of humoral autoimmunity.
Duke Scholars
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
November 2003
Volume
112
Issue
10
Start / End Page
1480 / 1482
Location
United States
Related Subject Headings
- Lupus Erythematosus, Systemic
- Immunology
- Immunization, Passive
- Humans
- CD40 Ligand
- Autoimmunity
- Autoantibodies
- Antibodies, Monoclonal
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kelsoe, G. (2003). Therapeutic CD154 antibody for lupus: promise for the future? J Clin Invest, 112(10), 1480–1482. https://doi.org/10.1172/JCI20371
Kelsoe, Garnett. “Therapeutic CD154 antibody for lupus: promise for the future?” J Clin Invest 112, no. 10 (November 2003): 1480–82. https://doi.org/10.1172/JCI20371.
Kelsoe G. Therapeutic CD154 antibody for lupus: promise for the future? J Clin Invest. 2003 Nov;112(10):1480–2.
Kelsoe, Garnett. “Therapeutic CD154 antibody for lupus: promise for the future?” J Clin Invest, vol. 112, no. 10, Nov. 2003, pp. 1480–82. Pubmed, doi:10.1172/JCI20371.
Kelsoe G. Therapeutic CD154 antibody for lupus: promise for the future? J Clin Invest. 2003 Nov;112(10):1480–1482.
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
November 2003
Volume
112
Issue
10
Start / End Page
1480 / 1482
Location
United States
Related Subject Headings
- Lupus Erythematosus, Systemic
- Immunology
- Immunization, Passive
- Humans
- CD40 Ligand
- Autoimmunity
- Autoantibodies
- Antibodies, Monoclonal
- 42 Health sciences
- 32 Biomedical and clinical sciences